Anti-Human Dopamine beta Hydroxylase Antibody [A691]
Anti-Human Dopamine beta Hydroxylase Antibody [A691] with collaborator-tested evidence for IHC. Read more ›
["IHC"]Product Description
Dopamine beta Hydroxylase is the stated target for this antibody product. The listing uses collaborator-supplied technical data from Elabscience and is structured for research-use-only antibody selection through ABMIUM.
Product profile: reactivity: Human; host: Rabbit; clonality: Monoclonal; clone: A691; isotype: IgG, κ; available conjugation options: Unconjugated.
Application evidence: Elabscience lists this product for IHC. In the ABMIUM matrix, these listed applications are marked C to show collaborator-tested ABMIUM Verified evidence. Applications not listed in the supplied data remain marked N.
Technical notes: immunogen: Peptide. This information is proprietary to PTMab.; purification: Protein A purified; concentration: 1 mg/mL.
Database references: UniProt: P09172.
Research Use Only.
Key Facts
| Target | Dopamine beta Hydroxylase |
| Also known as | OTTHUMP, DBH, DBM, Dopamine beta hydroxylase, Dopamine beta monooxygenase, Dopamine beta-hydroxylase (dopamine beta-monooxygenase), Dopamine beta-monooxygenase, DOPO, OTTHUMP00000022501, Soluble dopamine beta-hydroxylase, dopamine beta-hydroxylase, Dopamine β-hydroxylase |
| Concentration | 1 mg/mL |
| Species reactivity | Human |
| Shelf life | 12 months from shipping dates |
| Research area | Neuroscience, Cancer, Metabolism |
| WB | IHC-P | IHC-FR | IF/ICC | FLOW CYT | IP | CHIP | IHC | |
|---|---|---|---|---|---|---|---|---|
| Human |
Specifications
Storage & Stability
Compliance & Certifications
Manufactured under ISO 9001:2015 quality management standards.
Manufactured under ISO 14001:2015 quality management standards.
Manufactured under ISO 45001:2018 quality management standards.
Not intended for diagnostic or therapeutic use.
Substance does not appear on the SVHC candidate list.